Clinical Trial Update: Clinical Benefits of Seroquel XR in Anxiety Disorder [Phase 3]

View source ↗

Summary

Phase 3 update reports potential clinical benefits of Seroquel XR in anxiety disorders (with schizophrenia listed among conditions studied).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Schizophrenia

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: Corporation de Recherche en Neuropsycho Pharmacologie de Quebec | Conditions: Schizophrenia, Anxiety | Phase 3 | Status: UNKNOWN